In cardia gastric cancer, GG carriers showed a higher expression of PLCE1(1.08 fold, compared with that AA carriers; P = 0.91), while in noncardia gastric cancer, AG carriers showed a 1.52 fold higher expression of PLCE1 than that of the AA carriers (P = 0.96) (Figure 2C). This evidence concerns the gene PLCE1 and gastric cancer.